Royal Bank of Canada’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16K Buy
1,120
+606
+118% +$8.66K ﹤0.01% 5958
2025
Q1
$6K Sell
514
-574
-53% -$6.7K ﹤0.01% 5922
2024
Q4
$25K Sell
1,088
-403
-27% -$9.26K ﹤0.01% 5533
2024
Q3
$63K Buy
1,491
+492
+49% +$20.8K ﹤0.01% 5132
2024
Q2
$36K Buy
+999
New +$36K ﹤0.01% 5414
2024
Q1
Sell
-104
Closed -$2K 6818
2023
Q4
$2K Buy
+104
New +$2K ﹤0.01% 6280
2023
Q3
Sell
-30
Closed 6834
2023
Q2
$0 Buy
30
+20
+200% ﹤0.01% 6996
2023
Q1
$0 Hold
10
﹤0.01% 6837
2022
Q4
$0 Sell
10
-16
-62% ﹤0.01% 7002
2022
Q3
$0 Buy
26
+15
+136% ﹤0.01% 7153
2022
Q2
$0 Sell
11
-172
-94% ﹤0.01% 7042
2022
Q1
$7K Sell
183
-264
-59% -$10.1K ﹤0.01% 6625
2021
Q4
$43K Buy
447
+158
+55% +$15.2K ﹤0.01% 5921
2021
Q3
$42K Sell
289
-82
-22% -$11.9K ﹤0.01% 5743
2021
Q2
$68K Sell
371
-103
-22% -$18.9K ﹤0.01% 5344
2021
Q1
$117K Buy
474
+60
+14% +$14.8K ﹤0.01% 4867
2020
Q4
$117K Buy
414
+112
+37% +$31.7K ﹤0.01% 4708
2020
Q3
$72K Sell
302
-262
-46% -$62.5K ﹤0.01% 4681
2020
Q2
$187K Sell
564
-2,870
-84% -$952K ﹤0.01% 4053
2020
Q1
$781K Buy
3,434
+916
+36% +$208K ﹤0.01% 2829
2019
Q4
$621K Sell
2,518
-2,541
-50% -$627K ﹤0.01% 3273
2019
Q3
$289K Buy
5,059
+1,452
+40% +$82.9K ﹤0.01% 3662
2019
Q2
$170K Buy
+3,607
New +$170K ﹤0.01% 3998
2019
Q1
Hold
0
5859
2018
Q4
Hold
0
6010
2018
Q3
Hold
0
6207
2015
Q3
Sell
-750
Closed -$104K 6077
2015
Q2
$104K Buy
750
+747
+24,900% +$104K ﹤0.01% 4324
2015
Q1
$0 Buy
+3
New ﹤0.01% 5740